Atlas Trials

Adenovirus Infection

17 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Adenovirus Infection

RecordFirmDate
Posoleucel (ALVR105) for the Treatment of Adenovirus Infection in Pediatric and Adult Participants Receiving Standard of Care Following Allogeneic Hematopoietic Cell Transplantation (NCT05179057)AlloVir2022-04-26
Study of Posoleucel (ALVR105,Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant (NCT05305040)AlloVir2022-03-24
Pilot Study of Haploidentical Donor Adenovirus Specific T-lymphocytes to Treat Refractory Adenovirus Infections (NCT04722029)Nationwide Children's Hospital2021-10-01
Posoleucel (ALVR105, Formerly Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant (NCT04693637)AlloVir2021-01-15
Antiviral Cellular Therapy for Enhancing T-cell Reconstitution Before or After Hematopoietic Stem Cell Transplantation (NCT03475212)Pediatric Transplantation & Cellular Therapy Consortium2018-06-20
Most Closely Human Leukocyte Antigen (HLA)-Matched Adenovirus-specific T Lymphocytes (Viralym-A) (NCT02276820)AlloVir2017-12-07
Virus-specific ImmunoTherapy Following Allogeneic Stem Cell Transplantation (NCT02702427)St. Anna Kinderkrebsforschung2016-08-03
A Study to Assess Safety and Feasibility of Direct Infusions of Donor-derived Virus-specific T-cells in Recipients of Hematopoietic Stem Cell Transplantation With Post-transplant Viral Infections Using the Cytokine Capture System® (NCT02007356)University Hospital, Basel, Switzerland2014-12-01
Study to Assess the Safety and Efficacy of Brincidofovir in Treatment of Early Versus Late Adenovirus Infection (NCT02087306)Jazz Pharmaceuticals2014-03-01
Clinical Grade Adenovirus Specific T Cells for Immunotherapy After Allogeneic Stem Cell Transplantation (CTL-ADV) (NCT02851576)Central Hospital, Nancy, France2011-08-01
Administration of Rapidly Generated Multivirus-specific Cytotoxic T-Lymphocytes (VIRAGE) (NCT01070797)Baylor College of Medicine2011-01-01
Safety, Toxicity and MTD of One Intravenous IV Injection of Donor CTLs Specific for CMV and Adenovirus (NCT00880789)Baylor College of Medicine2009-05-01
Most Closely HLA Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL) (NCT00711035)Baylor College of Medicine2008-11-01
Administration of Virus-Specific Cytotoxic T-Lymphocytes (NCT00590083)Baylor College of Medicine2003-07-01
TETRAVI Expanded Access Program (NCT07104591)Baylor College of Medicine

Track Adenovirus Infection automatically

Every clearance here is in the API, with alerts when new ones post.